LifeScienceXchange

LifeScienceXchange offers actionable market insights, technology showcases, thought leadership and essential news, all in a condensed and curated video format. Through these we unite the entire early-stage R&D ecosystem with a shared mission: to accelerate the discovery and development of transformative, life-changing medicines.

Advancing Formulation Development: Lonza Capsugel Technology Showcase

Oral delivery remains the preferred route of administration, yet many innovative therapies present significant formulation challenges. Acid-sensitive molecules, poorly absorbed compounds, biologics and emerging modalities often need advanced delivery approaches to achieve their full potential. Discover how Capsugel combines decades of capsule expertise, enteric technologies such as Capsugel® Enprotect®, and the Innovaform® Accelerator Center to support the next generation of oral therapies.
Capsugel® Enprotect® Capsule An innovative capsule for enteric delivery with no post-filling coating required for low pH protection
Advancing Oral Drug Delivery: The Innovation Behind Capsugel® Enprotect® Capsule
Next-Generation Capsules: Emerging Technologies in Capsule Fabrication and Targeted Oral Drug Delivery
Revolutionizing Enteric Delivery: Unveiling the Performance of Capsugel® Enprotect® Capsules
Lipid-Based Formulation in Customized Enteric Capsule for Oral GLP-1 Receptor Agonist Peptide Delivery
Homepage banner option 1

Thought Leadership

Oral GLP-1 Delivery: From Scientific Barriers to Breakthrough Potential

Oral GLP-1 Delivery: From Scientific Barriers to Breakthrough Potential

Andreas Bernkop-Schnürch Professor, University of Innsbruck
Vivek Gupta Associate Professor, St. John’s University
Jitendra Kumar Lead Scientist, Chemistry & Process Development, Entos Pharmaceuticals
Severin Schneebeli Associate Professor, Organic Chemistry, Industrial and Molecular Pharmaceutics, Purdue University
Interview with Paul Workman

Interview with Paul Workman

Paul Workman Professor of Pharmacology and Therapeutics, Institute of Cancer Research
Chemical Inducers of Proximity – Non-Degrading Molecular Glue Modalities

Chemical Inducers of Proximity – Non-Degrading Molecular Glue Modalities

Rick Ewing Vice President, Head of Chemistry, Rapafusyn Pharmaceuticals
Zoran Rankovic Director, Centre for Chemical Biology & Therapeutics, St. Jude Children’s Research Hospital
Kyle Eastman VP and Head of Chemistry, Halda Therpeutics
Danette Daniels Vice President of the Protein Degrader Platform, Foghorn Therapeutics
Advancing Drug Discovery Ebook Ad

Market Insight: Across R&D Stages